Cargando…

P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales: Oikonomou, Athanasios, Valsecchi, Luigia, Quadri, Manuel, Watrin, Titus, Scharov, Katerina, Tu, Jia-Wey, Bhatia, Sanil, Bardini, Michela, Fazio, Grazia, Borkhardt, Arndt, Palmi, Chiara, Cazzaniga, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428381/
http://dx.doi.org/10.1097/01.HS9.0000968212.76470.de
_version_ 1785090455400087552
author Oikonomou, Athanasios
Valsecchi, Luigia
Quadri, Manuel
Watrin, Titus
Scharov, Katerina
Tu, Jia-Wey
Bhatia, Sanil
Bardini, Michela
Fazio, Grazia
Borkhardt, Arndt
Palmi, Chiara
Cazzaniga, Giovanni
author_facet Oikonomou, Athanasios
Valsecchi, Luigia
Quadri, Manuel
Watrin, Titus
Scharov, Katerina
Tu, Jia-Wey
Bhatia, Sanil
Bardini, Michela
Fazio, Grazia
Borkhardt, Arndt
Palmi, Chiara
Cazzaniga, Giovanni
author_sort Oikonomou, Athanasios
collection PubMed
description
format Online
Article
Text
id pubmed-10428381
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283812023-08-17 P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Oikonomou, Athanasios Valsecchi, Luigia Quadri, Manuel Watrin, Titus Scharov, Katerina Tu, Jia-Wey Bhatia, Sanil Bardini, Michela Fazio, Grazia Borkhardt, Arndt Palmi, Chiara Cazzaniga, Giovanni Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428381/ http://dx.doi.org/10.1097/01.HS9.0000968212.76470.de Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Oikonomou, Athanasios
Valsecchi, Luigia
Quadri, Manuel
Watrin, Titus
Scharov, Katerina
Tu, Jia-Wey
Bhatia, Sanil
Bardini, Michela
Fazio, Grazia
Borkhardt, Arndt
Palmi, Chiara
Cazzaniga, Giovanni
P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
title P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_full P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_fullStr P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_full_unstemmed P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_short P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_sort p325: applications of high-throughput drug screening as drug repurposing strategy for poor outcome subgroups of pediatric b-cell precursor acute lymphoblastic leukemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428381/
http://dx.doi.org/10.1097/01.HS9.0000968212.76470.de
work_keys_str_mv AT oikonomouathanasios p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT valsecchiluigia p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT quadrimanuel p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT watrintitus p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT scharovkaterina p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT tujiawey p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT bhatiasanil p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT bardinimichela p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT faziograzia p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT borkhardtarndt p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT palmichiara p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia
AT cazzanigagiovanni p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia